Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $13.98 USD
Change Today -0.03 / -0.21%
Volume 453.8K
RDEN On Other Exchanges
Symbol
Exchange
Berlin
As of 1:40 PM 07/2/15 All times are local (Market data is delayed by at least 15 minutes).

elizabeth arden inc (RDEN) Key Developments

Elizabeth Arden, Inc. Reports Unaudited Consolidated Earnings Results for the Third Quarter and Nine Months Ended March 31, 2015; Provides Earnings Guidance for the Fourth Quarter of Fiscal 2015; Provides Capital Expenditures Guidance for Fiscal Year 2015

Elizabeth Arden, Inc. reported unaudited consolidated earnings results for the third quarter and nine months ended March 31, 2015. For the quarter, net sales were $191.7 million against $210.8 million last year. On an adjusted basis, net sales were $191.4 million, against $210.8 million last year, a decrease of 9.2% or 6.0% at constant foreign currency rates. Loss before income taxes was $34.4 million against $35.6 million last year. Net loss attributable to shareholders was $34.4 million against $26.4 million last year. Net loss attributable to common shareholders was $35.1 million or $1.18 per basic and diluted share against $26.4 million or $0.89 per basic and diluted share last year. LBITDA was $15.9 million against $15.7 million last year. Adjusted net loss attributable to common shareholders was $25.7 million or $0.86 per basic and diluted share against $24.9 million or $0.84 per basic and diluted share last year. Adjusted LBITDA was $15.7 million against $12.4 million last year. Adjusted loss before income taxes was $34.3 million against $32.2 million last year. Adjusted net loss attributable to shareholders was $25.1 million against $24.9 million last year. For the nine months, net sales were $795.6 million against $972.6 million last year. Loss before income taxes was $115.8 million against income before income taxes of $11.5 million last year. Net loss attributable to shareholders was $115.9 million against net income attributable to shareholders of $10.2 million last year. Net loss attributable to common shareholders was $137.6 million or $4.62 per basic and diluted share against net income attributable to common shareholders of $10.2 million or $0.34 per basic and diluted share last year. LBITDA was $56.3 million against EBITDA of $68.8 million last year. Adjusted net loss attributable to common shareholders was $30.1 million or $1.01 per basic and diluted share against adjusted net income attributable to common shareholders of $14.5 million or $0.48 per diluted share last year. Adjusted EBITDA was $16.6 million against $72.2 million last year. Net cash provided by operating activities was $40.6 million against net cash used in operating activities of $35.1 million last year. On an adjusted basis, net sales were $810.6 million against $972.6 million last year. Adjusted loss before income taxes was $42.9 million against adjusted income before income taxes of $14.9 million last year. Adjusted net loss attributable to shareholders was $28.6 million against adjusted net income attributable to shareholders of $14.5 million last year. On an adjusted basis, net sales represent a decrease of 16.7% from the prior year, or 15.6% at constant foreign currency rates. The company currently expects the following for the fourth quarter of fiscal 2015 as compared to the prior year period: net sales increases in the International segment versus the prior year period at constant currency rates with continued declines in celebrity fragrances impacting the North America segment; gross margin expansion due to better sales mix, lower discounts and realization of reduced supply chain and product costs; improved EBITDA margins from gross margin expansion and lower selling, general and administrative expenses. The company expects capital expenditures for fiscal year 2015 to total approximately $26 million to $28 million.

Elizabeth Arden Seeks Acquisitions

Rod Little, Executive Vice President and Chief Financial Officer of Elizabeth Arden, Inc. (NasdaqGS:RDEN) said, "We continue to assess opportunities to acquire or license fragrance brands to refill the pipeline and better leverage our global infrastructure."

Elizabeth Arden, Inc. to Report Q3, 2015 Results on May 07, 2015

Elizabeth Arden, Inc. announced that they will report Q3, 2015 results at 9:30 AM, Eastern Standard Time on May 07, 2015

Elizabeth Arden, Inc., Q3 2015 Earnings Call, May 07, 2015

Elizabeth Arden, Inc., Q3 2015 Earnings Call, May 07, 2015

Elizabeth Arden, Inc. Reports Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended December 31, 2014; Provides Earnings Guidance for the Second Half of Fiscal 2015 and Provides Capital Expenditures Guidance for the Fiscal 2015

Elizabeth Arden, Inc. reported unaudited consolidated earnings results for the second quarter and six months ended December 31, 2014. For the quarter, the company reported net sales of $333,607,000 compared to $418,137,000 a year ago. Loss before income taxes was $56,066,000 compared to income before income taxes of $45,040,000 a year ago. Net loss attributable to the company’s shareholders was $56,139,000 or $1.90 per diluted share compared to net income attributable to the company’s shareholders of $34,953,000 or $1.16 per diluted share a year ago. Adjusted to exclude non-recurring costs, net of taxes, net income attributable to the company’s shareholders was $8,517,000 or $0.28 per diluted share compared to $32,650,000 or $1.08 per diluted share a year ago. Adjusted EBITDA was $31,047,000 compared to $57,415,000 a year ago. LBITDA was $35,599,000 compared to EBITDA of $63,898,000 a year ago. For the six months period, the company reported net sales of $603,985,000 compared to $761,746,000 a year ago. Loss before income taxes was $81,347,000 compared to income before income taxes of $47,042,000 a year ago. Net loss attributable to the company’s shareholders was $81,489,000 or $3.44 per diluted share compared to net income attributable to the company’s shareholders of $36,650,000 or $1.21 per diluted share a year ago. Adjusted to exclude non-recurring costs, net of taxes, net loss attributable to the company’s shareholders was $4,423,000 or $0.15 per diluted share compared to net income attributable to the company of $39,402,000 or $1.30 per diluted share a year ago. Adjusted EBITDA was $32,326,000 compared to $84,547,000 a year ago. Net cash provided by operating activities was $37,136,000 compared to $15,233,000 a year ago. Capital expenditures totaled $14.6 million, which compares to $25.8 million of capital spending in the prior year period. LBITDA was $40,412,000 compared to EBITDA of $84,461,000 a year ago. The company currently expects the following for the second half of fiscal 2015: net sales increases in the International segment versus the prior year period at constant currency rates with continued declines in celebrity fragrances impacting the North American segment; gross margin expansion due to improved pricing, better sales mix, lower discounts and realization of reduced supply chain and product costs; improved EBITDA margins from gross margin expansion and lower selling, general and administrative expenses; stronger cash flow from operations from improved working capital. The company expects capital expenditures for fiscal 2015 to total approximately $30 million.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
RDEN:US $13.98 USD -0.03

RDEN Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lifetime Brands Inc $15.03 USD -0.07
Oriflame Cosmetics SA kr127.10 SEK -3.40
Perfumania Holdings Inc $5.62 USD 0.00
Weight Watchers International Inc $4.19 USD -0.49
View Industry Companies
 

Industry Analysis

RDEN

Industry Average

Valuation RDEN Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 0.4x
Price/Book 1.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ELIZABETH ARDEN INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.